Pharm prime vendor fleet
Ended Awarded
- Contract number
- SPE2DU25F0K82
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,510
Award facts
- Contract value 100% obligated
- $12,509.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,509.69 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, falls under the SPE2DB Indefinite Delivery Contract program—a $500 million single-award vehicle through which DLA procures comprehensive pharmaceutical supplies for military health facilities. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive positioning in federal procurement markets. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare systems nationwide.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of delivery orders covering an extensive range of medical products including prescription medications, vaccines, oncology treatments, specialty injections, and contraceptive devices. The company's registration in SAM.gov since 2001 and its consistent success in securing contracts with DLA underscore its established capability to meet the agency's complex pharmaceutical distribution requirements. This delivery order represents one of numerous procurement actions executed under the larger SPE2DB contract vehicle, enabling DLA to efficiently fulfill pharmaceutical supply needs across military health facilities with streamlined ordering and rapid delivery capabilities.
Quick answers
Who was awarded contract SPE2DU25F0K82?
SPE2DU25F0K82 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DU25F0K82 worth?
The government has obligated $12,510 on SPE2DU25F0K82.
Is contract SPE2DU25F0K82 an order under another contract?
Yes. SPE2DU25F0K82 is a delivery order under SPE2DU25D9815, an indefinite delivery contract.
Was contract SPE2DU25F0K82 competed?
The extent of competition for SPE2DU25F0K82 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award